A POOLED ANALYSIS OF THE IMPACT OF AGE ON OUTCOMES IN PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE

被引：0

作者：

Palumbo, A. ^{[1
]}

Dimopoulos, M. A. ^{[2
]}

Richardson, P. G. ^{[3
]}

Siegel, D. S. ^{[4
]}

Cavo, M. ^{[5
]}

Corradini, P. ^{[6
]}

Weisel, K. C. ^{[7
]}

Delforge, M. ^{[8
]}

Chen, C. ^{[9
]}

Goldschmidt, H. ^{[10
,11
]}

Jagannath, S. ^{[12
]}

Lockhorst, H. M. ^{[13
]}

Moreau, P. ^{[14
]}

Plesner, T.

Sternas, L. ^{[16
]}

Peluso, T. ^{[15
,17
]}

Hong, K. ^{[16
]}

Herring, J. ^{[16
]}

Yu, X. ^{[16
]}

Zaki, M. H. ^{[16
]}

San Miguel, J. ^{[18
]}

机构：

[1] Univ Turino, Turin, Italy

[2] Univ Athens, Athens, Greece

[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA USA

[4] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA

[5] Univ Bologna, Sch Med, Seragnoli Inst Hematol, Bologna, Italy

[6] Univ Milan, Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[7] Univ Hosp Tuebingen, Tubingen, Germany

[8] Univ Hosp Leuven, Leuven, Belgium

[9] Princess Margaret Hosp, Toronto, ON, Canada

[10] Univ Hosp Heidelberg, Heidelberg, Germany

[11] German Canc Res Ctr, Heidelberg, Germany

[12] Mt Sinai Hosp, New York, NY 10029 USA

[13] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[14] Univ Hosp Hotel Dieu, Nantes, France

[15] Univ Southern Denmark, Dept Hematol, Ctr Little Belt, Vejle Hosp, Vejle, Denmark

[16] Celgene Corp, Summit, NJ USA

[17] Celgene Int Sarl, Boudry, Switzerland

[18] Univ Navarra Clin, CIMA, IDISNA, Pamplona, Spain

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

E1295

引用

页码：535 / 536

页数：2

共 50 条

[31] Pomalidomide plus Low-Dose Dexamethasone plus Daratumumab in Relapsed and/or Refractory Multiple Myeloma after Lenalidomide-Based Treatment Failure
Siegel, David S.
Schiller, Gary J.
Samaras, Christy J.
Sebag, Michael
Berdeja, Jesus G.
Ganguly, Siddhartha
Matous, Jeffrey V.
Song, Kevin
Seet, Christopher S.
Talamo, Giampaolo
Acosta-Rivera, Mirelis
Bar, Michael
Quick, Donald P.
Anz, Bertrand
Fonseca, Gustavo
Reece, Donna
Agarwal, Amit
Chung, Weiyuan
Zafar, Faiza
Bahlis, Nizar
BLOOD, 2018, 132
[32] Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Shah, Jatin
Usmani, Saad
Stadtmauer, Edward A.
Rifkin, Robert M.
Berenson, James R.
Berdeja, Jesus G.
Lyons, Roger M.
Klippel, Zandra
Chang, Yu-Lin
Niesvizky, Ruben
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (09): : 570 - +
[33] Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment
Dao-bin Zhou
Li Yu
Xin Du
Jie Jin
Zhen Cai
Fangping Chen
Xiaoyan Ke
Xiao Li
Depei Wu
Fanyi Meng
Huisheng Ai
Jingshan Zhang
Dena DeMarco
Nianhang Chen
Jay Mei
Jianmin Wang
Jian Hou
International Journal of Hematology, 2015, 101 : 569 - 577
[34] Pomalidomide (POM) with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Outcomes Based on Prior Treatment Exposure
Vij, Ravi
Hofmeister, Craig C.
Richardson, Paul G.
Jagannath, Sundar
Siegel, David S.
Baz, Rachid
Chen, Min
Zaki, Mohamed
Larkins, Gail
Anderson, Kenneth C.
BLOOD, 2012, 120 (21)
[35] Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
Richardson, Paul G.
Perrot, Aurore
San-Miguel, Jesus
Beksac, Meral
Spicka, Ivan
Leleu, Xavier
Schjesvold, Fredrik
Moreau, Philippe
Dimopoulos, Meletios A.
Huang, Jeffrey Shang-Yi
Minarik, Jiri
Cavo, Michele
Prince, H. Miles
Malinge, Laure
Dubin, Franck
van de Velde, Helgi
Anderson, Kenneth C.
LANCET ONCOLOGY, 2022, 23 (03): : 416 - 427
[36] Impact of Lenalidomide Plus Low-Dose Dexamethasone Treatment on Immune Cell Populations of the Patients with Refractory/Relapsed Multiple Myeloma
Lee, Sung-Eun
Lim, Ji-Young
Ryu, Da-Bin
Kim, Tae Woo
Jeon, Young-Woo
Yoon, Jae-Ho
Cho, Byung-Sik
Eom, Ki-Seong
Kim, Yoo-Jin
Kim, Hee-Je
Lee, Seok
Cho, Seok-Goo
Kim, Dong-Wook
Lee, Jong Wook
Min, Woo-Sung
Min, Chang-Ki
BLOOD, 2015, 126 (23)
[37] Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment
Zhou, Dao-bin
Yu, Li
Du, Xin
Jin, Jie
Cai, Zhen
Chen, Fangping
Ke, Xiaoyan
Li, Xiao
Wu, Depei
Meng, Fanyi
Ai, Huisheng
Zhang, Jingshan
DeMarco, Dena
Chen, Nianhang
Mei, Jay
Wang, Jianmin
Hou, Jian
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (06) : 569 - 577
[38] Analysis of renal impairment in MM-003, a phase III study of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in refractory or relapsed and refractory multiple myeloma
Weisel, Katja C.
Dimopoulos, Meletios A.
Moreau, Philippe
Lacy, Martha Q.
Song, Kevin W.
Delforge, Michel
Karlin, Lionel
Goldschmidt, Hartmut
Banos, Anne
Oriol, Albert
Alegre, Adrian
Chen, Christine
Cavo, Michele
Garderet, Laurent
Ivanova, Valentina
Martinez-Lopez, Joaquin
Knop, Stefan
Yu, Xin
Hong, Kevin
Sternas, Lars
Jacques, Christian
Zaki, Mohamed H.
Miguel, Jesus San
HAEMATOLOGICA, 2016, 101 (07) : 872 - 878
[39] Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma
Murakami, Hirokazu
Handa, Hiroshi
Abe, Masahiro
Iida, Sinsuke
Ishii, Akihiro
Ishikawa, Takayuki
Ishida, Tadao
Oota, Masatsugu
Ozaki, Shuji
Kosaka, Masaaki
Sakai, Akira
Sawamura, Morio
Shimazaki, Chihiro
Shimizu, Kazuyuki
Takagi, Toshiyuki
Hata, Hiroyuki
Fukuhara, Takashi
Fujii, Hiroshi
Miyata, Akira
Wakayama, Toshio
Takatsuki, Kiyoshi
EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (03) : 234 - 239
[40] Analyzing the relationship of response and survival in patients with refractory or relapsed and refractory multiple myeloma (RRMM) treated with pomalidomide plus low-dose dexamethasone (POM plus LoDEX) in the MM-003 trial.
Weisel, Katja
Moreau, Philippe
Gibson, Craig J.
Song, Kevin W.
Saunders, Owain
Sternas, Lars Axel
Hong, Kevin
Zaki, Mohamed H.
Dimopoulos, Meletios A.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →